483 Aurolife Pharma Jun 2018

483 Aurolife Pharma Jun 2018

Adetutu Gidado FDA, Frederick Razzaghi FDA, Adetutu Gidado FDA, Frederick Razzaghi FDA$119.00 - Available Now

FDA investigators audited the Aurolife Pharma - Dayton, NJ, United States facility and issued inspectional observations (via FDA 483) on 14 Jun 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 14 Jun 2018
  • Location: Dayton, United States
  • FEI: 3005796917
Add To Cart